BN Business News
Adicionar empresa →
Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.

Regulação e direito · 26/11/19961 min de leitura

Intent to Grant an Exclusive License to SciClone Pharmaceuticals

Tradução automática local · Idioma original da fonte

Resumo

In compliance with 37 CFR Sec. 404 et seq., the Department of the Army hereby gives notice of its intent to grant to SciClone Pharmaceuticals, a corporation having its principal place of business at 90 Mariner's Island Blvd., San Mateo, CA 94404, an exclusive license under U.S. Patent Applications Serial Numbers 07/878,372 filed 4 May 1992 and 08/145,660 filed 4 November 1993 respectively, and all continuations, continuations-in-part, divisionals, and reissues of the same, and all corresponding foreign patent applications which have been or will be filed. These applications relate to a composition for and a method of treating hepatitis C. Objections along with supporting evidence, if any, should be filed within 60 days from the date of this notice.

Idioma original da fonte: Federal Register — All DocumentsAbrir o comunicado original →

Explorar análises

Análises empresariais →